Platelet substitutes
Executive Summary
Workshop co-sponsored by FDA, National Institutes of Health and the U.S. Army will address definition of efficacy for platelet substitutes and other issues surrounding in vivo efficacy of platelet substitutes and platelet transfusion products. The meeting is set for Sept. 28 at 8 a.m. in Wilson Hall, Bldg. 1, NIH